Comparative Pharmacology
Head-to-head clinical analysis: MICONAZOLE NITRATE COMBINATION PACK versus SELENIUM SULFIDE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MICONAZOLE NITRATE COMBINATION PACK versus SELENIUM SULFIDE.
MICONAZOLE NITRATE COMBINATION PACK vs SELENIUM SULFIDE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Miconazole nitrate inhibits fungal lanosterol 14α-demethylase (CYP51), disrupting ergosterol synthesis and causing fungal cell membrane damage.
Selenium sulfide is an antifungal and cytostatic agent. It reduces sebum production and inhibits the growth of Malassezia species by interfering with fungal lipid metabolism and cell wall synthesis. The exact molecular mechanism is not fully elucidated.
Intravaginally, one suppository (100 mg miconazole nitrate) once daily at bedtime for 7 days or one suppository (200 mg) once daily for 3 days, combined with topical application of miconazole nitrate cream (2%) to the vulvar area twice daily for 7 days.
Topical: 2.5% lotion or shampoo applied to affected area once daily for 7 days; 1% shampoo used once or twice weekly for maintenance.
None Documented
None Documented
Terminal elimination half-life is approximately 20-25 hours, but can be prolonged to 30-40 hours in patients with hepatic impairment.
Not established; due to negligible systemic absorption, a terminal half-life is not clinically relevant. If absorbed, selenium has a long biological half-life of approximately 65–115 days due to incorporation into selenoproteins.
Primarily fecal (biliary) as unchanged drug and metabolites (~50-60%); renal excretion accounts for <20% of the dose, mostly as inactive metabolites.
Selenium sulfide is minimally absorbed after topical application. The small absorbed fraction is excreted renally as selenite or selenate, with fecal excretion of unabsorbed drug accounting for >90% of the dose.
Category A/B
Category A/B
Antifungal
Antifungal / Antiseborrheic